These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7690921)

  • 41. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
    Ozturk M
    J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
    Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
    Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 48. Pitfall in the diagnosis of ectopic pregnancy: immunocytochemical evaluation in a patient with false-negative serum beta-hCG levels.
    Taylor RN; Padula C; Goldsmith PC
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1035-8. PubMed ID: 2453820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First-trimester serum levels of the beta-subunit of human chorionic gonadotropin in a tubal molar pregnancy.
    Chase JS; Check JH; Nowroozi K; Wu CH
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):910. PubMed ID: 2445209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J; Rosenshein NB; Block BS
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N; Mutirangura A; Limpongsanurak S
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Partial hydatidiform mole with significantly increased serum HCG levels in the triploidy syndrome].
    Arnholdt H; Elser H; Dörmer P
    Geburtshilfe Frauenheilkd; 1984 May; 44(5):328-32. PubMed ID: 6565615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydatidiform mole with non-metastatic pulmonary complications and a false low level of hCG.
    Flam F; Hambraeus-Jonzon K; Hansson LO; Kjaeldgaard A
    Eur J Obstet Gynecol Reprod Biol; 1998 Apr; 77(2):235-7. PubMed ID: 9578284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of serum beta-hCG levels with myosalpingeal invasion and viable trophoblast mass in tubal pregnancy.
    Oktay K; Brzyski RG; Miller EB; Krugman D
    Obstet Gynecol; 1994 Nov; 84(5):803-6. PubMed ID: 7524002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
    Boyko WL; Russell HT
    Obstet Gynecol; 1979 Dec; 54(6):737-45. PubMed ID: 514561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False Negative Urine Pregnancy Testing with Complete Molar Pregnancy: An Example of the Hook Effect.
    Anderson Z; Larson E; Khan M; Bell M
    S D Med; 2016 Feb; 69(2):55-7. PubMed ID: 26999911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
    Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
    Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.